Pregnancy with epilepsy: Obstetric and neonatal outcome of a controlled study

Seizure

Volumn 19, Issue 2, 2010, Pages 112-119

  Mawer, G ^a   Briggs, M ^a   Baker, G A ^b   Bromley, R ^b   Coyle, H ^a   Eatock, J ^b   Kerr, L ^c   Kini, U ^a   Kuzmyshcheva, L ^a   Lucas, S B ^a   Wyatt, L ^c   Clayton Smith, J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Antiepileptic drugs; Epilepsy; Pregnancy outcome; Teratogenicity

Indexed keywords

CARBAMAZEPINE; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; OXAZEPAM; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ARTICLE; CONGENITAL MALFORMATION; DELIVERY; EPILEPSY; FEMALE; FETUS DEATH; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; INJURY; INTERVIEW; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MEDICAL RECORD; NEWBORN; NEWBORN DEATH; PARITY; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; VAGINAL DELIVERY;

ANTICONVULSANTS; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; EPILEPSY; FEMALE; HUMANS; INFANT, NEWBORN; OBSERVATION; OBSTETRIC LABOR COMPLICATIONS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 76349109022     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.11.008     Document Type: Article

References (38)

1. Delgado-Escueta A.V., and Janz D. Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 42 (1992) 149-160
2. Olafsson E., Hallgrimsson J.T., Hauser W.A., Ludvigsson P., and Gudmundsson G. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 39 (1998) 887-892
3. Al Bunyan M., and Abo-Talib Z. Outcome of pregnancies in epileptic women: a study in Saudi Arabia. Seizure 8 (1999) 26-29
4. Fairgrieve S.D., Jackson M., Jonas P., Walshaw D., White K., Montgomery T.L., et al. Population based, prospective study of the care of women with epilepsy in pregnancy. British Medical Journal 321 (2000) 674-675
5. EURAP. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy and pregnancy registry. Neurology 66 (2006) 354-360
6. Meador K.J., Baker G.A., Finnell R.H., Kalayjian L.A., Liporace J.D., Loring D.W., et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology 67 (2006) 407-412
7. Viinikainen K., Heinonen S., Eriksson K., and Kalviainen R. Community-based, prospective controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 47 (2006) 186-192
8. Robertson I.G. Breech presentation associated with anticonvulsant drugs. Journal of Obstetrics and Gynaecology 4 (1984) 174-177
9. Wilhelm J., Morris D., and Hotham N. Epilepsy and pregnancy-a review of 98 pregnancies. Australian and New Zealand Journal of Obstetrics and Gynaecology 30 (1990) 290-295
10. Laskowska M., Leszczynska-Gorzelak B., and Oleszczuk J. Pregnancy in women with epilepsy. Gynecologic and Obstetric Investigation 51 (2001) 99-102
11. Richmond J.R., Krishnamoorthy P., Andermann E., and Benjamin A. Epilepsy and pregnancy: an obstetric perspective. American Journal of Obstetrics and Gynecology 190 (2004) 371-379
12. In: Iheanacho I. (Ed). Anti-epileptics, pregnancy and the child. Drug and Therapeutics Bulletin 43 (2005) 13-16
13. Canger R., Battino D., Canevini M.P., Fumarola C., Guidolin L., Vignoli A., et al. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40 (1999) 1231-1236
14. Vajda F.J., O'Brien T.J., Hitchcock A., Graham J., and Lander C. The Australian registry of antiepileptic drugs in pregnancy: experience after 30 months. Journal of Clinical Neuroscience 10 (2003) 543-549
15. Vajda F.J., O'Brien T.J., Hitchcock A., Graham J., Cook M., Lander C., et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of antiepileptic drugs in pregnancy. Journal of Clinical Neuroscience 11 (2004) 854-858
16. Morrow J., Russell A., Guthrie E., Parsons L., Robertson I., Waddell R., et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. Journal of Neurology Neurosurgery and Psychiatry 77 (2006) 193-198
17. Wyszynski D.F., Nambisan M., Surve T., Alsdorf R.M., Smith C.R., and Holmes L.B. Antiepileptic Drug Register. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64 (2005) 961-965
18. Teramo K., and Hiilesmaa V.K. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In: Janz D., Dam M., Richens A., Bossi L., Helge H., and Schmidt D. (Eds). Epilepsy, pregnancy, and the child (1982), Raven Press, New York 53-59
19. CEMACH. Report of confidential enquiries into maternal and child health in the United Kingdom. Why mothers die (2000-2002) (2004), CEMACH, London p. 187-188
20. Meador K.J., Reynolds M.W., Crean S., Fahrbach K., and Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and met-analysis of published pregnancy registries and cohorts. Epilepsy Research 81 (2008) 1-13
21. Meador K.J., Baker G.A., Browning N., Clayton-Smith J., Combs-Cantrell D.T., Cohen M., et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. New England Journal of Medicine 360 (2009) 1597-1605
22. EUROCAT. Central Registry. Instructions for the registration and surveillance of congenital anomalies (2005). http://www.eurocat.ulster.ac.uk/
23. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: management issues for women with epilepsy (summary statement) Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 51 (2005) 944-948
24. Gaily E., Kantola-Sorsa E., Hiilesmaa V., Isoaho M., Matila R., Kotila M., et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62 (2004) 28-32
25. Wallace H., Shorvon S.D., Hopkins A., O'Donoghue M., and Guideline Development Group. Contraception and pregnancy. Adults with poorly controlled epilepsy (1997), Royal College of Physicians, London p. 19-23
26. Crawford P., Appleton R., Betts T., Duncan J., Guthrie E., and Morrow J. Best practice guidelines for the management of women with epilepsy. Seizure 8 (1999) 201-217
27. Wide K., Winbladh B., and Kallen B. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide population-based register study. Acta Paediatrica 93 (2004) 174-176
28. Hvas C.L., Henriksen T.B., Ostergaard J.R., and Dam M. Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birth weight. British Journal of Obstetrics and Gynaecology 107 (2000) 896-902
29. Bromfield E.B., Dworetzky B.A., Wyszynski D.F., Smith C.R., Baldwin E.J., and Holmes L.B. Valproate tetatogenicity and epilepsy syndrome. Epilepsia 49 (2008) 2122-2124
30. Morrow J.I., Hunt S.J., Russell A.J., Smithson W.H., Parsons L., Robertson I., et al. Folic acid use and major congenital malformations in offspring of women with epilepsy. A prospective study from the UK Epilepsy and Pregnancy Register. Journal of Neurology Neurosurgery and Psychiatry 80 (2009) 506-511
31. Pittschieler S., Brezinka C., Jahn B., Trinka E., Unterberger I., Dobesberger J., et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. Journal of Neurology 255 (2008) 1926-1931
32. Mattson R.H., Cramer J.A., and Collins J.F. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic clonic seizures. New England Journal of Medicine 327 (1992) 765-771
33. Nicolson A., Appleton R.E., Chadwick D.W., and Smith D.F. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. Journal of Neurology Neurosurgery and Psychiatry 75 (2004) 75-79
34. Marson A.G., Al Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., et al. The SANAD study of effectiveness of valproate, lamotrigine or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. The Lancet 369 (2007) 1016-1026
35. Coppola G., Auricchio G., Federico R., Carotenuto M., and Pascotto A. Lamotrigine versus valproic acid as first line monotherapy in newly diagnosed typical absence seizures: an open label, randomised parallel group study. Epilepsia 45 (2004) 1049-1053
36. Mohanraj R., and Brodie M.J. Outcomes of newly diagnosed idiopathic generalised epilepsy syndromes in a non-paediatric setting. Acta Neurologica Scandinavica 115 (2007) 204-208
37. Adab N., Kini U., Vinten J., Ayres J., Baker G., Clayton-Smith J., et al. The longer term outcome of children born to mothers with epilepsy. Journal of Neurology Neurosurgery and Psychiatry 75 (2004) 1575-1583
38. Vinten J., Adab N., Kini U., Gorry J., Gregg J., and Baker G.A. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64 (2005) 949-954